The Burden of Celiac Disease in Canada: More Work Needed to Lighten the Load
Bibliographic record
Abstract
C eliac disease was first recognized as a distinct clinical entity more than 60 years ago.However, its full spectrum and impact have only been appreciated over the past decade.In part, this reflects the increasing availability of serological testing that has enabled earlier diagnosis, and a greater appreciation of the protean clinical manifestations and high prevalence of gluten sensitivity.In the current issue of the Canadian Journal of Gastroenterology, Pulido et al (1) (pages 449-453) surveyed the memberships of the Canadian Celiac Association and the Fondation Quebecoise de la Maladie Coeliaque to characterize a Canadian adult population with celiac disease.Remarkably, 5912 of 10,693 invitees responded.Key findings included an average diagnostic delay of 12.0 years and a high prevalence of persistent symptoms despite the avoidance of gluten.Methodological shortfalls, however, must be acknowledged.Most notably, the retrospective survey design is prone to both response bias and recall bias, and members of national celiac organizations represent a highly selected subset of the overall population with celiac disease.Nonetheless, these data provide useful insight into the symptom burden and clinical challenges faced by patients with celiac disease.To some extent, delayed diagnosis of celiac is understandable, given that 'classic' presentations are now rare and many patients initially present with extraintestinal signs such as anemia.However, diagnostic delay can have important health consequences that range from persistent symptoms to micronutrient deficiencies and even malignancies.There is ample evidence that celiac disease remains underdiagnosed in Western populations and that its incidence is increasing (2).What is the solution?Population-based screening remains controversial; however, better education of health care providers and proactive screening of those at increased risk could help.In Canada, more consistent access to serological screening assays is needed because not all provincial health ministries reimburse the test.The primary treatment for celiac disease is elimination of gluten from the diet on diagnosis (3).For most patients, this is highly effective, but persistent symptoms are common, as demonstrated by Pulido et al (1).There are three potential explanations for such therapeutic failure.Some patients have symptoms unrelated to gluten sensitivity, and other competing etiologies must be investigated.Other patients may either surreptitiously or unintentionally continue to ingest gluten, which mandates a careful review of diet and other environmental exposures.However, the most challenging scenario is that of refractory celiac disease, for which novel approaches are needed.Nonresponsive celiac disease is classified as either type I, in which duodenal lymphocytic infiltration resembles untreated disease, or type II, in which lymphocytes carry an abnormal immunophenotype with oligoclonal expansion.The prognosis of the latter is less favourable.The traditional medical approach to such patients has included corticosteroids and immunosuppression.However, a number of novel and targeted approaches to nonresponsive disease are on the horizon.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.002 | 0.010 |
| Meta-epidemiology (narrow) | 0.001 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.001 | 0.002 |
| Science and technology studies | 0.007 | 0.003 |
| Scholarly communication | 0.004 | 0.003 |
| Open science | 0.002 | 0.001 |
| Research integrity | 0.014 | 0.014 |
| Insufficient payload (model declined to judge) | 0.009 | 0.002 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".